创新医疗
(002173)
| 流通市值：42.46亿 | | | 总市值：45.01亿 |
| 流通股本：4.16亿 | | | 总股本：4.41亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 193,334,481.58 | 816,018,808.41 | 610,403,522.18 | 408,040,808.16 |
| 营业收入 | 193,334,481.58 | 816,018,808.41 | 610,403,522.18 | 408,040,808.16 |
| 二、营业总成本 | 205,240,260.34 | 875,716,000.54 | 636,374,560.84 | 417,087,062.79 |
| 营业成本 | 176,013,067.63 | 752,326,293.78 | 549,235,540.15 | 359,936,326.97 |
| 税金及附加 | 2,593,266.39 | 11,219,298.91 | 8,406,806.62 | 5,730,453.92 |
| 销售费用 | 2,151,638.32 | 9,376,130.32 | 7,847,677.8 | 4,135,533.55 |
| 管理费用 | 24,404,821.16 | 105,516,509.94 | 76,443,328.95 | 51,057,964.97 |
| 财务费用 | 77,466.84 | -2,722,232.41 | -5,558,792.68 | -3,773,216.62 |
| 其中:利息费用 | 692,165.59 | 4,090,769.8 | 2,049,213.27 | 1,113,519.73 |
| 其中:利息收入 | 1,078,577.96 | 7,915,770.68 | 9,309,805.45 | 6,080,949.39 |
| 加:公允价值变动收益 | 1,273,245.4 | 6,328,693.68 | 2,617,698.8 | 278,672.9 |
| 加:投资收益 | -2,098,085.95 | -4,348,134.7 | -1,902,403.77 | -1,117,134.37 |
| 资产处置收益 | - | -1,422,556.57 | -625,408.72 | -625,408.72 |
| 资产减值损失(新) | - | -205,586.91 | -88,310.69 | -88,310.69 |
| 信用减值损失(新) | -1,076,263.6 | -2,449,376.98 | -3,964,805.78 | -4,784,215.17 |
| 其他收益 | 287,655.62 | 1,460,767.66 | 1,779,292.03 | 768,424.52 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -13,519,227.29 | -60,333,385.95 | -28,154,976.79 | -14,614,226.16 |
| 加:营业外收入 | 14,561.92 | 2,390,610.58 | 5,239,610.2 | 5,103,278.07 |
| 减:营业外支出 | 428,322.68 | 42,691,774.33 | 6,091,138.49 | 5,543,942.29 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -13,932,988.05 | -100,634,549.7 | -29,006,505.08 | -15,054,890.38 |
| 减:所得税费用 | -42,319.74 | -6,646,277.2 | -1,309,645.32 | 830,260.35 |
| 六、净利润 | -13,890,668.31 | -93,988,272.5 | -27,696,859.76 | -15,885,150.73 |
| 持续经营净利润 | -13,890,668.31 | -93,988,272.5 | -27,696,859.76 | -15,885,150.73 |
| 归属于母公司股东的净利润 | -13,937,418.26 | -93,954,030.31 | -27,844,147.16 | -16,029,593.18 |
| 少数股东损益 | 46,749.95 | -34,242.19 | 147,287.4 | 144,442.45 |
| (一)基本每股收益 | -0.03 | -0.21 | -0.06 | -0.04 |
| (二)稀释每股收益 | -0.03 | -0.21 | -0.06 | -0.04 |
| 九、综合收益总额 | -13,890,668.31 | -93,988,272.5 | -27,696,859.76 | -15,885,150.73 |
| 归属于母公司股东的综合收益总额 | -13,937,418.26 | -93,954,030.31 | -27,844,147.16 | -16,029,593.18 |
| 归属于少数股东的综合收益总额 | 46,749.95 | -34,242.19 | 147,287.4 | 144,442.45 |
| 公告日期 | 2025-04-28 | 2025-04-12 | 2024-10-25 | 2024-08-10 |
| 审计意见(境内) | | 标准无保留意见 | | |